Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Great Novel Therapeutics Biotech & Medicals Corp. (7427) Financial Statements

Great Novel Therapeutics Biotech & Medicals Corp. Financial Overview

Great Novel Therapeutics Biotech & Medicals Corp.'s market cap is currently NT$3.14B. The company's EPS TTM is NT$-2.46; its P/E ratio is -24.47; Great Novel Therapeutics Biotech & Medicals Corp. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueNT$ 1.21MNT$ 1.69MNT$ 4.85MNT$ 540.00KNT$ 630.00K
Gross ProfitNT$ -8.87MNT$ 1.01MNT$ 4.81MNT$ 464.00KNT$ 283.00K
Operating IncomeNT$ -99.54MNT$ -112.65MNT$ -65.82MNT$ -57.44MNT$ -36.52M
EBITDANT$ -91.86MNT$ -97.86MNT$ -57.11MNT$ -53.96MNT$ -35.08M
Net IncomeNT$ -97.47MNT$ -104.92MNT$ -61.54MNT$ -55.78MNT$ -35.86M
Balance Sheet
Cash & Short-Term InvestmentsNT$ 447.54MNT$ 582.76MNT$ 476.55MNT$ 247.58MNT$ 125.10M
Total AssetsNT$ 526.75MNT$ 662.60MNT$ 644.85MNT$ 372.85MNT$ 229.96M
Total DebtNT$ 7.85MNT$ 10.46MNT$ 14.38MNT$ 833.00KNT$ 860.00K
Net DebtNT$ -21.99MNT$ -144.59MNT$ -165.18MNT$ -110.25MNT$ -61.93M
Total LiabilitiesNT$ 23.77MNT$ 29.28MNT$ 26.81MNT$ 12.05MNT$ 21.61M
Stockholders' EquityNT$ 502.98MNT$ 633.32MNT$ 618.04MNT$ 360.80MNT$ 208.35M
Cash Flow
Free Cash FlowNT$ -88.13MNT$ -80.31MNT$ -57.92MNT$ -78.39MNT$ -61.92M
Operating Cash FlowNT$ -87.85MNT$ -76.85MNT$ -54.99MNT$ -65.81MNT$ -33.92M
Investing Cash FlowNT$ 9.37MNT$ -133.49MNT$ -182.78MNT$ -89.21MNT$ -90.32M
Financing Cash FlowNT$ -46.74MNT$ 185.84MNT$ 306.24MNT$ 203.31MNT$ 120.00M

Currency in TWD

Great Novel Therapeutics Biotech & Medicals Corp. Earnings and Revenue History

-120M-60M060M-450000 %-300000 %-150000 %0 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin
Income Statement >

Great Novel Therapeutics Biotech & Medicals Corp. Liabilities to Assets

0250M500M750M0 %8 %16 %24 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets
Balance Sheet >

Great Novel Therapeutics Biotech & Medicals Corp. Cash Flow

-300M-200M-100M0100M200M300M400M201720182019202020212022202320242025OperatingInvestingFinancing
Cash Flow >

Great Novel Therapeutics Biotech & Medicals Corp. Forecast EPS vs Actual EPS

Earnings >